Global Kidney Cancer Therapeutics and Diagnostics Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Cystoscopy
  • 1.2.3 Biopsy
  • 1.2.4 Intravenous Pyelogram
  • 1.2.5 CT Scan
  • 1.2.6 Kidney Ultrasound
  • 1.2.7 Others
• 1.3 Market by Application
  • 1.3.1 Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Pharmaceutical Labs
  • 1.3.4 Genomics Laboratories
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Kidney Cancer Therapeutics and Diagnostics Market Perspective (2017-2028)
• 2.2 Kidney Cancer Therapeutics and Diagnostics Growth Trends by Region
  • 2.2.1 Kidney Cancer Therapeutics and Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Region (2017-2022)
  • 2.2.3 Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028)
• 2.3 Kidney Cancer Therapeutics and Diagnostics Market Dynamics
  • 2.3.1 Kidney Cancer Therapeutics and Diagnostics Industry Trends
  • 2.3.2 Kidney Cancer Therapeutics and Diagnostics Market Drivers
  • 2.3.3 Kidney Cancer Therapeutics and Diagnostics Market Challenges
  • 2.3.4 Kidney Cancer Therapeutics and Diagnostics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Kidney Cancer Therapeutics and Diagnostics Players by Revenue
  • 3.1.1 Global Top Kidney Cancer Therapeutics and Diagnostics Players by Revenue (2017-2022)
  • 3.1.2 Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Players (2017-2022)
• 3.2 Global Kidney Cancer Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Kidney Cancer Therapeutics and Diagnostics Revenue
• 3.4 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio
  • 3.4.1 Global Kidney Cancer Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics and Diagnostics Revenue in 2021
• 3.5 Kidney Cancer Therapeutics and Diagnostics Key Players Head office and Area Served
• 3.6 Key Players Kidney Cancer Therapeutics and Diagnostics Product Solution and Service
• 3.7 Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Type

• 4.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Type (2017-2022)
• 4.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028)

5 Kidney Cancer Therapeutics and Diagnostics Breakdown Data by Application

• 5.1 Global Kidney Cancer Therapeutics and Diagnostics Historic Market Size by Application (2017-2022)
• 5.2 Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
• 6.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type
  • 6.2.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
  • 6.2.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
  • 6.2.3 North America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
• 6.3 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application
  • 6.3.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
  • 6.3.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
  • 6.3.3 North America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
• 6.4 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country
  • 6.4.1 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
  • 6.4.2 North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
• 7.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type
  • 7.2.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
  • 7.2.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
  • 7.2.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
• 7.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application
  • 7.3.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
  • 7.3.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
  • 7.3.3 Europe Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
• 7.4 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country
  • 7.4.1 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
  • 7.4.2 Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
• 8.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type
  • 8.2.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application
  • 8.3.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region
  • 8.4.1 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
• 9.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type
  • 9.2.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
  • 9.2.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
  • 9.2.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
• 9.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application
  • 9.3.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
  • 9.3.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
  • 9.3.3 Latin America Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
• 9.4 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country
  • 9.4.1 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
  • 9.4.2 Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size (2017-2028)
• 10.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type
  • 10.2.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application
  • 10.3.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country
  • 10.4.1 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Company Details
  • 11.1.2 Bayer Business Overview
  • 11.1.3 Bayer Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.1.4 Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.1.5 Bayer Recent Developments
• 11.2 Hoffmann La Roche
  • 11.2.1 Hoffmann La Roche Company Details
  • 11.2.2 Hoffmann La Roche Business Overview
  • 11.2.3 Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.2.4 Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.2.5 Hoffmann La Roche Recent Developments
• 11.3 GlaxoSmithKline
  • 11.3.1 GlaxoSmithKline Company Details
  • 11.3.2 GlaxoSmithKline Business Overview
  • 11.3.3 GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.3.4 GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.3.5 GlaxoSmithKline Recent Developments
• 11.4 Novartis
  • 11.4.1 Novartis Company Details
  • 11.4.2 Novartis Business Overview
  • 11.4.3 Novartis Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.4.4 Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.4.5 Novartis Recent Developments
• 11.5 Pfizer
  • 11.5.1 Pfizer Company Details
  • 11.5.2 Pfizer Business Overview
  • 11.5.3 Pfizer Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.5.4 Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.5.5 Pfizer Recent Developments
• 11.6 Abbott Laboratories
  • 11.6.1 Abbott Laboratories Company Details
  • 11.6.2 Abbott Laboratories Business Overview
  • 11.6.3 Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.6.4 Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.6.5 Abbott Laboratories Recent Developments
• 11.7 Amgen
  • 11.7.1 Amgen Company Details
  • 11.7.2 Amgen Business Overview
  • 11.7.3 Amgen Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.7.4 Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.7.5 Amgen Recent Developments
• 11.8 Genentech
  • 11.8.1 Genentech Company Details
  • 11.8.2 Genentech Business Overview
  • 11.8.3 Genentech Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.8.4 Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.8.5 Genentech Recent Developments
• 11.9 Cerulean Pharma
  • 11.9.1 Cerulean Pharma Company Details
  • 11.9.2 Cerulean Pharma Business Overview
  • 11.9.3 Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.9.4 Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.9.5 Cerulean Pharma Recent Developments
• 11.10 Seattle Genetics
  • 11.10.1 Seattle Genetics Company Details
  • 11.10.2 Seattle Genetics Business Overview
  • 11.10.3 Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Introduction
  • 11.10.4 Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
  • 11.10.5 Seattle Genetics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Cystoscopy
• Table 3. Key Players of Biopsy
• Table 4. Key Players of Intravenous Pyelogram
• Table 5. Key Players of CT Scan
• Table 6. Key Players of Kidney Ultrasound
• Table 7. Key Players of Others
• Table 8. Global Kidney Cancer Therapeutics and Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 9. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 10. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
• Table 11. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2017-2022)
• Table 12. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 13. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region (2023-2028)
• Table 14. Kidney Cancer Therapeutics and Diagnostics Market Trends
• Table 15. Kidney Cancer Therapeutics and Diagnostics Market Drivers
• Table 16. Kidney Cancer Therapeutics and Diagnostics Market Challenges
• Table 17. Kidney Cancer Therapeutics and Diagnostics Market Restraints
• Table 18. Global Kidney Cancer Therapeutics and Diagnostics Revenue by Players (2017-2022) & (US$ Million)
• Table 19. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Players (2017-2022)
• Table 20. Global Top Kidney Cancer Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2021)
• Table 21. Ranking of Global Top Kidney Cancer Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2021
• Table 22. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2017-2022)
• Table 23. Key Players Headquarters and Area Served
• Table 24. Key Players Kidney Cancer Therapeutics and Diagnostics Product Solution and Service
• Table 25. Date of Enter into Kidney Cancer Therapeutics and Diagnostics Market
• Table 26. Mergers & Acquisitions, Expansion Plans
• Table 27. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
• Table 28. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2017-2022)
• Table 29. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 30. Global Kidney Cancer Therapeutics and Diagnostics Revenue Market Share by Type (2023-2028)
• Table 31. Global Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
• Table 32. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Application (2017-2022)
• Table 33. Global Kidney Cancer Therapeutics and Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 34. Global Kidney Cancer Therapeutics and Diagnostics Revenue Share by Application (2023-2028)
• Table 35. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
• Table 36. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
• Table 37. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
• Table 38. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
• Table 39. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
• Table 40. North America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
• Table 41. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
• Table 42. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
• Table 43. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
• Table 44. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
• Table 45. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
• Table 46. Europe Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
• Table 51. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
• Table 52. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size by Region (2023-2028) & (US$ Million)
• Table 53. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
• Table 54. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
• Table 55. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
• Table 56. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
• Table 57. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
• Table 58. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Type (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Application (2023-2028) & (US$ Million)
• Table 63. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2017-2022) & (US$ Million)
• Table 64. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size by Country (2023-2028) & (US$ Million)
• Table 65. Bayer Company Details
• Table 66. Bayer Business Overview
• Table 67. Bayer Kidney Cancer Therapeutics and Diagnostics Product
• Table 68. Bayer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 69. Bayer Recent Developments
• Table 70. Hoffmann La Roche Company Details
• Table 71. Hoffmann La Roche Business Overview
• Table 72. Hoffmann La Roche Kidney Cancer Therapeutics and Diagnostics Product
• Table 73. Hoffmann La Roche Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 74. Hoffmann La Roche Recent Developments
• Table 75. GlaxoSmithKline Company Details
• Table 76. GlaxoSmithKline Business Overview
• Table 77. GlaxoSmithKline Kidney Cancer Therapeutics and Diagnostics Product
• Table 78. GlaxoSmithKline Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 79. GlaxoSmithKline Recent Developments
• Table 80. Novartis Company Details
• Table 81. Novartis Business Overview
• Table 82. Novartis Kidney Cancer Therapeutics and Diagnostics Product
• Table 83. Novartis Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 84. Novartis Recent Developments
• Table 85. Pfizer Company Details
• Table 86. Pfizer Business Overview
• Table 87. Pfizer Kidney Cancer Therapeutics and Diagnostics Product
• Table 88. Pfizer Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 89. Pfizer Recent Developments
• Table 90. Abbott Laboratories Company Details
• Table 91. Abbott Laboratories Business Overview
• Table 92. Abbott Laboratories Kidney Cancer Therapeutics and Diagnostics Product
• Table 93. Abbott Laboratories Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 94. Abbott Laboratories Recent Developments
• Table 95. Amgen Company Details
• Table 96. Amgen Business Overview
• Table 97. Amgen Kidney Cancer Therapeutics and Diagnostics Product
• Table 98. Amgen Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 99. Amgen Recent Developments
• Table 100. Genentech Company Details
• Table 101. Genentech Business Overview
• Table 102. Genentech Kidney Cancer Therapeutics and Diagnostics Product
• Table 103. Genentech Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 104. Genentech Recent Developments
• Table 105. Cerulean Pharma Company Details
• Table 106. Cerulean Pharma Business Overview
• Table 107. Cerulean Pharma Kidney Cancer Therapeutics and Diagnostics Product
• Table 108. Cerulean Pharma Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 109. Cerulean Pharma Recent Developments
• Table 110. Seattle Genetics Company Details
• Table 111. Seattle Genetics Business Overview
• Table 112. Seattle Genetics Kidney Cancer Therapeutics and Diagnostics Product
• Table 113. Seattle Genetics Revenue in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
• Table 114. Seattle Genetics Recent Developments
• Table 115. Research Programs/Design for This Report
• Table 116. Key Data Information from Secondary Sources
• Table 117. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Type: 2021 VS 2028
• Figure 2. Cystoscopy Features
• Figure 3. Biopsy Features
• Figure 4. Intravenous Pyelogram Features
• Figure 5. CT Scan Features
• Figure 6. Kidney Ultrasound Features
• Figure 7. Others Features
• Figure 8. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Application: 2021 VS 2028
• Figure 9. Hospitals Case Studies
• Figure 10. Pharmaceutical Labs Case Studies
• Figure 11. Genomics Laboratories Case Studies
• Figure 12. Others Case Studies
• Figure 13. Kidney Cancer Therapeutics and Diagnostics Report Years Considered
• Figure 14. Global Kidney Cancer Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 15. Global Kidney Cancer Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 16. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Region: 2021 VS 2028
• Figure 17. Global Kidney Cancer Therapeutics and Diagnostics Market Share by Players in 2021
• Figure 18. Global Top Kidney Cancer Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics and Diagnostics as of 2021)
• Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics and Diagnostics Revenue in 2021
• Figure 20. North America Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
• Figure 21. North America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
• Figure 22. North America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
• Figure 23. North America Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
• Figure 24. United States Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 25. Canada Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. Europe Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
• Figure 27. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
• Figure 28. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
• Figure 29. Europe Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
• Figure 30. Germany Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. France Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. U.K. Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Italy Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 34. Russia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 35. Nordic Countries Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Asia-Pacific Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
• Figure 37. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
• Figure 38. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
• Figure 39. Asia Pacific Kidney Cancer Therapeutics and Diagnostics Market Size Share by Region (2017-2028)
• Figure 40. China Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. Japan Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. South Korea Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 43. Southeast Asia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 44. India Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 45. Australia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 46. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
• Figure 47. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
• Figure 48. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
• Figure 49. Latin America Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
• Figure 50. Mexico Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 51. Brazil Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. Middle East & Africa Kidney Cancer Therapeutics and Diagnostics Market Size YoY (2017-2028) & (US$ Million)
• Figure 53. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Type (2017-2028)
• Figure 54. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size Market Share by Application (2017-2028)
• Figure 55. Middle East and Africa Kidney Cancer Therapeutics and Diagnostics Market Size Share by Country (2017-2028)
• Figure 56. Turkey Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 57. Saudi Arabia Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 58. UAE Kidney Cancer Therapeutics and Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 59. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 60. Hoffmann La Roche Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 61. GlaxoSmithKline Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 62. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 63. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 64. Abbott Laboratories Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 65. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 66. Genentech Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 67. Cerulean Pharma Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 68. Seattle Genetics Revenue Growth Rate in Kidney Cancer Therapeutics and Diagnostics Business (2017-2022)
• Figure 69. Bottom-up and Top-down Approaches for This Report
• Figure 70. Data Triangulation
• Figure 71. Key Executives Interviewed